Ingenio® Solution Provides Comparable Efficiency on Amaxa® Nucleofector®. Cells were electroporated in parallel with an EGFP reporter vector using a Nucleofector® II Device (Amaxa®) and either the Ingenio® Electroporation Solution or the Nucleofector® Kit V (Amaxa®) according to Amaxa®’s recommended protocol for each cell line [HL-60 (T-019), Jurkat E6-1(X-001), K-562 (T-016), THP-1 (V-001), SK-N-MC (A-023), and MCF-7 (P020)]. EGFP expressing cells were identified 24 hours post-electroporation by flow cytometry and presented as a percentage of the live cell population.

Ingenio® Solution Shows Similar Results with Amaxa® Nucleofector® and Other Electroporators. Ingenio® Solution used with Gene Pulser Electroporator Yields Comparable High Efficiency to the Amaxa® Nucleofector® II System: HL-60, Jurkat E6-1, K562, THP-1 and SK-N-MC cells were electroporated with the same EGFP reporter on the same day, using either Ingenio® Electroporation Solution in the Gene Pulser XCell (Bio-Rad®) (red bars) or the Amaxa® Solution V in Amaxa® Nucleofector® II (Lonza) (light grey bars).

Ingenio® Provides Both Superior Efficiency and Cell Viability Compared to Other Solutions. Cells were electroporated in parallel with an EGFP reporter vector using either Ingenio® Electroporation Solution, PBS or the Gene Pulser Electroporation Buffer (Bio-Rad®) on the Gene Pulser Xcell™ Eukaryotic System. (A) EGFP expressing cells were identified 24 hours post-electroporation by flow cytometry and presented as a percentage of the live cell population. (B) Cells were assayed for viablility by propidium iodide staining and flow cytometry analysis. Experiments were performed in triplicate on three separate days and the data averaged.